STEFANIE ACOSTA: Open Payments
NPI 1629538665 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 29 payments from 15 companies in 2025. Trend: 2023 $222 · 2024 $654 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $162 |
| ABBVIE INC. | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| PFIZER INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| TOLMAR, INC. | 2 | $37 |
| Antares Pharma, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Lundbeck LLC | 1 | $23 |
| Amgen Inc. | 1 | $19 |
Products named: Kerendia, REXULTI, UBRELVY, FARXIGA, JATENZO, XYOSTED, QULIPTA, Cologuard Collection Kit.
Industry payments across LA — which companies pay providers there.
